Open Access

A novel transurethral resection technique for superficial bladder tumor: retrograde en bloc resection

  • Kai-Yan Zhang1,
  • Jin-Chun Xing1Email author,
  • Wei Li1,
  • Zhun Wu1,
  • Bin Chen1 and
  • Dong-Yu Bai2
World Journal of Surgical Oncology201715:125

DOI: 10.1186/s12957-017-1192-6

Received: 25 March 2017

Accepted: 22 June 2017

Published: 6 July 2017

Abstract

Background

Transurethral resection of bladder tumor (TURBT) is the standard approach to bladder tumors but suffers from several disadvantages. The aim of this study was to evaluate the safety and efficacy of a novel procedure of retrograde en bloc resection of bladder tumor (RERBT) with conventional monopolar resection electrode for the treatment of superficial bladder tumors.

Methods

RERBT and conventional TURBT (C-TURBT) were conducted, respectively, in 40 and 50 patients diagnosed with superficial papillary bladder tumors. In the RERBT group, the tumors were en bloc removed retrogradely under direct vision using a conventional monopolar electrode. Patients’ clinicopathological, intraoperative, and postoperative data were compared retrospectively between the RERBT and C-TURBT groups.

Results

Of the 90 patients, 40 underwent RERBT and 50 underwent C-TURBT. Both groups were comparable in clinicopathological characteristic. RERBT could be performed as safely and effectively as C-TURBT. There were no significant differences in operative time and surgical complications. The cumulative recurrence rates between groups were similar during up to 18 months follow-up. The detrusor muscle could be identified pathologically in 100% of RERBT tumor specimens and the biopsy of tumor bases, but only in 54 and 70%, respectively, of C-TURBT samples (P < 0.01).

Conclusions

The RERBT technique is feasible and safe for superficial bladder tumors using conventional monopolar resection setting, with the advantages of adequate tumor resection and the ability to collect good quality tumor specimens for pathological diagnosis and staging compared to conventional TURBT.

Keywords

En-bloc resection Non-muscle-invasive bladder cancer Transurethral resection of bladder tumor

Background

Bladder cancer is the most common and second most common urological cancer in China and Western countries [1], respectively. Seventy percent of bladder cancer are non-muscle invasive at diagnosis [2] and treated by transurethral resection (TUR) of the tumors. Adequate initial resection coupled with accurate histological diagnosis of the resected tumors are essential to successful management of these tumors [3]. To date, transurethral resection of bladder tumor (TURBT) remains the gold standard for the treatment of non-muscle-invasive bladder cancer (NMIBC).

The goal of TURBT is to remove all visible lesions and provide viable tissues for accurate pathological diagnosis [4]. The detection of the detrusor muscle within the tissue was the most important parameter that is associated with recurrence-free survival [5]. However, staging on TURBT specimens is often inaccurate due to their poor quality [6] resulted from piecemeal resection of tumors and charring of the resected tissues by conventional TURBT (C-TURBT) technique [3].

Here we introduce a novel retrograde en bloc TURBT (RERBT) technique using conventional monopolar electrode and compared its safety and efficacy with C-TURBT. To the best of our knowledge, this is the first report on en bloc resection of bladder tumor without any adjustment of electrode loop and use of alternative energy or facilities.

Methods

Study population

From October 2014 to December 2015, data of 90 consecutive patients with pathologically diagnosed primary NMIBC after RERBT or C-TURBT in our hospital was reviewed retrospectively. RERBT or C-TURBT was performed by two urologists who were well trained and experienced with endoscopic practices. The cases were divided into two groups: the RERBT group (n = 40) and the C-TURBT group (n = 50) (Table 1). This study was approved by the Ethics Committee of Xiamen University Affiliated First Hospital.
Table 1

Clinicopathological characteristics of patients

Variable

RERBT (n = 40)

C-TURBT (n = 50)

P value

Age (year)

60.65 ± 13.08

60.80 ± 14.04

0.959

Size

  

0.650

 

≤3 cm (n)

32 (80%)

38 (76%)

 

>3 cm (n)

8 (20%)

12 (24%)

Gender

  

0.166

 

Male

35 (87.5%)

38 (76%)

 

Female

5 (12.5%)

12 (24%)

Tumor multiplicity

  

0.705

 

Single

29 (72.5%)

38 (76%)

 

Multiple

11 (27.5%)

12 (24%)

Tumor morphology

  

0.686

 

Pedunculate

28 (70%)

33 (66%)

 

Flat

12 (30%)

17 (34%)

Stage

  

0.119

 

Ta

15 (37.5%)

27 (54%)

 

T1

25 (62.5%)

23 (46%)

Grade (WHO2004)

  

0.250

 

LMP

9 (22.5%)

12 (24%)

 

LG

22 (55%)

23 (46%)

HG

9 (22.5%)

15 (30%)

Location

  

0.753

 

Lateral wall

22 (55%)

22 (44%)

 

Posterior wall

5 (12.5%)

8 (16%)

Anterior wall

6 (15%)

7 (14%)

Dome

0 (0)

3 (6%)

Trigone/bladder neck

4 (10%)

4 (8%)

Multiple

3 (7.5%)

6 (12%)

RERBT retrograde en bloc resection of bladder tumor, C-TURBT conventional transurethral resection of bladder tumor, LMP papillary urothelial neoplasia of low malignant potential, LG low-grade papillary urothelial carcinoma, HG high-grade papillary urothelial carcinoma

Surgical procedure

Both RERBT and C-TURBT were performed using the same Circom 25.6F continuous flow resectoscope with monopolar electrode loop (Richard Wolf GmbH, Knittlingen, Germany) and with cutting and coagulation power set at 110 and 75 W, respectively (Valley Lab, USA). All surgeries were performed in lithotomic position under general anesthesia. Tumor resections were performed routinely with a semi-filled bladder (filled with 200–300 mL irrigation fluid). Tumors less than 2.0 cm in diameter were retrieved under siphon effect. For those larger than 2.0 cm, Elik’s evacuator was used to retrieve the specimen. Biopsy of tumor bases and surrounding mucosa was performed routinely with cold cup forceps after the tumors were resected. The resected tumor was submitted for pathologic evaluation. We did not perform a second-look transurethral resection as a routine. The novel RERBT surgical procedure was approved by the Ethics Committee of Xiamen University Affiliated First Hospital.

RERBT

Macroscopic normal mucosa about 0.5–1.0 cm away from the tumor base was margined by using coagulation current. Blood vessels entering the tumor were blocked before resection to reduce intraoperative hemorrhage. Conventional monopolar electrode loop was used to push the bladder wall. After applying gentle pressure, the bladder mucosa was cut in a “flash-firing” fashion, which we called a “small bite.” When the deep muscle layer was reached, usually after one or two “small bites,” the loop was moved forward along the muscle layer using the same “small bite” cutting fashion, the base of the tumor was then lifted and pushed away step by step, and the tumor was resected in one piece retrogradely. All the procedures were performed under direct vision without the tumor body obstructing the view of incision position. The incision depth can be controlled by the amount of pressure applied to the bladder wall and the time of cutting. During cutting, bleeding vessels were coagulated simultaneously, keeping a clear vision of the field (Fig. 1 and Additional file 1).
Fig. 1

a A 1.5-cm-diameter bladder tumor on the right bladder wall. b Macroscopic normal mucosa about 0.5 cm away from the tumor base was margined. Then, the bladder mucosa was subsequently cut in a “flash-firing” fashion. c After the deep muscle layer was reached when normal glistening yellow fat is seen between muscle layers, the loop was moved forward along the muscle layer. d The tumor was resected in one piece

Additional file 1:

Video S1. A patient with a 1.0-cm-diameter lesion on the left bladder wall underwent RERBT. Initially, macroscopic normal mucosa about 0.5 cm away from the tumor base was margined by using coagulation current. Blood vessels entering the tumor were blocked before resection to reduce intraoperative hemorrhage. Conventional monopolar electrode loop was used to push the bladder wall. After applying gentle pressure, the bladder mucosa was cut in a “flash-firing” fashion, which we called a “small bite.” When the deep muscle layer was reached, usually after one or two “small bites,” the loop was moved forward along the muscle layer using the same “small bite” cutting technique, the base of the tumor was then lifted and pushed away step by step, and the tumor was resected in one piece retrogradely. (AVI 34285 kb)

For larger tumors, the protruding tumors were first removed superficially by conventional TURBT, and the remaining stalk and base lesion was removed en block by the novel procedure, avoiding disruption of the tumor base architecture before en bloc or divisional resection by RERBT.

C-TURBT

For conventional TURBT, a piece-by-piece resection to the muscle layer was performed.

Postoperative management

Intravesical instillation was performed with 40 mg pirarubicin dissolved into 50 mL of 5% glucose solution weekly for 8 weeks starting 1 week postoperatively, followed by monthly maintenance to 1 year. Follow-up included ultrasonography, cystoscopic examination, and urinalysis every 3 months for the first year and 6 months thereafter. The histological grades and tumor stages were assigned according to the WHO 2004 classification [7].

Statistical analysis

Statistical analyses were carried out with IBM SPSS Statistics ver. 20.0 (IBM Co., Armonk, NY, USA). Measurement data was analyzed with Student’s t tests. Categorical variables were compared using Pearson chi-square followed by Fisher’s exact test, and for continuous variables, the non-parametric Mann–Whitney test was used. A P value <0.05 was considered statistical significant.

Results

Forty and 50 patients received RERBT and C-TURBT, respectively. All tumors in both groups were papillary. Blood loss during the procedures was minimal, and no blood transfusion was required in all cases. The two groups had comparable clinicopathological characteristics including gender, age, tumor grade, tumor multiplicity, tumor size, and tumor location (Table 1). Table 2 lists the intra- and postoperative characteristics of RERBT vs. C-TURBT. According to the Clavien–Dindo classification for surgical complications [8], only Grade I and Grade II complications occurred in each group (Table 2). Intraoperative obturator nerve reflex occurred in both groups (22.5 and 24% in RERBT and C-TURBT groups, respectively, P = 0.867). Two (5%) patients in the RERBT group developed small bladder perforation which was managed by catheterization for 6 days before discharge. In contrast, four (8%) patients in the C-TURBT group had this complication (Table 2, P > 0.05). Pathological examination showed that the detrusor muscle was identifiable in both the tumor specimens and tumor base biopsies of all RERBT patients, suggesting adequate resection of the tumor. However, the detrusor muscle could only be seen in 54% of the tumor specimens and 70% of the tumor base biopsies of C-TURBT patients (P < 0.01). In addition, excised tumors showed that the lamina propria in the RERBT group remained intact compared to being severely charred in the C-TURBT group (Fig. 2).
Table 2

Perioperative and follow-up data

Variable

RERBT (n = 40)

C-TURBT (n = 50)

P value

Operative time (min)

36 ± 11.8

34 ± 13.6

0.464

Complications

  

0.7633

 Grade I

1 (2.5%)

2 (4%)

 

 Grade II

6 (15%)

8 (16%)

 

 Grade III

0

0

 

 Obturator nerve reflex

9 (22%)

12 (24%)

0.867

 Bladder perforation

2 (5%)

4 (8%)

0.689

Presence of the detrusor muscle

 Tumor specimen

(40/40) 100%

(27/50) 54%

0.000

 Tumor base

(40/40) 100%

(35/50) 70%

0.000

Irrigation (day)

1.16 ± 0.41

1.22 ± 0.45

0.518

Catheterization (day)

4.25 ± 2.04

4.65 ± 2.16

0.373

Postoperative hospital stay (day)

4.07 ± 0.57

4.18 ± 0.59

0.400

Residual tumor on the base

0

2 (5%)

0.500

Follow-up (months)

10.8 ± 3.9

11.3 ± 4.22

0.775

Cumulative recurrence

 In field

2 (5%)

5 (10%)

0.455

 Out of field

6 (15%)

7 (14%)

0.893

 Over all

8 (20%)

12 (24%)

0.650

 LMP

0

0

-

 LG

1 (2.5%)

2 (4%)

0.693

 HG

7 (17.5%)

10 (20%)

0.763

RERBT retrograde en bloc resection of bladder tumor, C-TURBT conventional transurethral resection of bladder tumor, LMP papillary urothelial neoplasia of low malignant potential, LG low-grade papillary urothelial carcinoma, HG high-grade papillary urothelial carcinoma

Fig. 2

Histologic findings of resected tumors. a The lamina propria mucosa was severely charred without muscular propria in a tumor in the C-TURBT group (×40). b The lamina propria mucosae remained intact, and the muscular propria was identified in a tumor in the RERBT group (×40)

All cases were performed with at least one episode of the cystoscope during up to 18 months follow-up (3~18 months). The overall cumulative recurrence of RERBT and C-TURBT was 20 and 24%, respectively (P = 0.650) (Table 2). Most recurrence occurred in high-grade patients and was likely out of the previous resection field.

Discussion

TURBT is the standard surgical procedure for non-muscle-invasive bladder cancer [5]. However, it does not follow the basic oncologic surgical principle of en bloc resection with up to 51% of specimens lacking the detrusor muscle and subsequently resulting in a high rate of incomplete resection up to 78% and high recurrence rates (50~70%) [9].

Theoretically, en bloc resection of bladder tumor (ERBT) could reduce recurrence rates due to complete tumor removal and reduction of tumor dispersal [9, 10]. For this reason, ERBT was recently identified as a promising TUR technique at the meeting of the European Association of Urology (EAU) section of Uro-Technology and the section of Uro-Oncology [11].

Innovative resectoscope modifications or alternative instruments have been developed to achieve the intention of en bloc resection. Initially, en bloc resection was described by Ukai et al. [12] which allows en bloc resections by making a circular incision around the tumor and including a 0.5-cm safety margin with a J-shaped needle electrode. Recently, Hurle et al. [13] also report a series of prospective data using the same J-shaped needle electrode.

Matthew described an endoscopic snare resection technique (ESRBT) using an electrosurgical polypectomy snare to achieve en bloc resection [9]. A relatively new idea was the grasp and bite technique, which can effectively be applied to small, flat, sessile lesions, but may not be suitable for a larger tumor [14]. Laser is another efficient alternative energy source to achieve en bloc resection of the bladder tumor [2, 15]. In addition to modified electrical loops and laser systems, water-jet-induced enucleation was reported by Nagele et al. [16] and Fritsche et al. [17] proving feasibility en bloc resection in tumor sizes up to 7.5 cm.

In this study, we reported yet another feasible and safe en bloc resection technique using only a conventional resectoscope and loop without any accessory equipment. The safety and efficacy of the novel technique were comparable to conventional TURBT. Each “small bite” of RERBT was performed under direct vision, which reduced the risk of cutting the bladder wall too deep or causing perforation. Once normal glistening yellow fat is seen between the muscle layers [6], the depth of incision was secured. Usually, it takes only one or two “small bites” to reach the muscle layer.

In order to avoid charring the surrounding mucosa and bladder perforation, the movement of the electrode is somewhat fast in conventional TURBT, resulting in difficult depth control of resection [18]. However, using the “small bite” cutting technique, the resection was performed step by step without a hasty movement and was safer than the conventional resection.

The reported risk of obturator nerve stimulation during TURBT is from 10.6 to 11.0%, which is the major reason for bladder perforation [14]. Comparable to the C-TURBT group, obturator reflex could not be avoided in the RERBT group (22.5 vs 24%, P = 0.867). However, by using general anesthesia and a muscle relaxant, obturator reflex could be reduced to an extent that it seldom caused severe complication such as perforation due to gentle “small bite” cutting fashion. Only two cases of bladder perforation occurred in the first 15 series. Both patients were discharged after 6 days of catheterization without any complication.

There is increasing evidence which proves that ERBT improves the quality of the resected specimens, and some results indicate that residual tumor in the second resection may be found in lower percentages [13, 19, 20]. The presence of muscular propria in the tumor specimen is crucial for accurately discriminating between stages pT1 and pT2 [21, 22]. However, conventional TURBT inevitably leads to fragmented tumor specimen with poor anatomic orientation due to piecemeal resection fashion. This will cause a substantial risk of understaging mainly for patients whose TURBT specimens do not contain the muscular propria [23, 24]. In additional, the existence of lamina propria in the RERBT specimen without obvious charring could facilitate accurate pathological diagnosis.

The muscle positive rate of tumor base biopsy in the RERBT group was 100%, while that of the C-TURBT group was only 70% (P < 0.01). Moreover, only 54% of resected specimen in the C-TURBT group included the muscularis propria, compared to 100% in the RERBT group (P < 0.01). The lower muscle positive rate both in the resected specimen and the tumor base biopsy in C-TURBT was attributed to incomplete resection. Tissue charring or vaporization of the tumor itself may cause difficulties for pathologists in identifying muscle layers. On the contrary, our approach used a technique involving dissection primarily into normal-appearing tissues under direct vision and avoided excessive burning of tissues, reducing the possibility of pathological false judgment of specimen postoperatively.

With the “small bite” resection fashion, the operative time of RERBT was estimated to be longer. Actually, time consumption of the RERBT group was comparable to the C-TURBT group, (36 ± 11.8 min vs. 34 ± 13.6 min, P = 0.464). This may be due to the precise and efficient incision of RERBT under a clearer vision. On the contrary, poor visibility secondary to intraoperative bleeding might increase the difficulty of the operation and lead to residual tumors on the C-TURBT arm [25].

Similar to conventional C-TURBT, the RERBT technique could have difficulties in a posterior- or dome-located tumor due to inconvenient resection angle. Although this could be overcome by using suprapubic pressure and nearly emptying the bladder, we do not recommend performing the RERBT procedure in dome-located tumors.

It is possible to retrieve tumors up to 4.5 cm by using a nephroscopy sheet and a laparoscopic grasp [26]. However, the loop might be covered by the tumor itself during the retrograde resection when it was more than 4.0 cm in diameter. Therefore, the protruding tumor can be first removed superficially by the conventional TURBT followed by the novel technique to remove the remaining stalk and base lesion, avoiding disruption of the tumor base architecture. Furthermore, since one of the advantages of RERBT is to provide a better quality of resection of the tumor base, we believed that it would be more suitable for a larger tumor (>2 cm). Our study had certain inherent limitations due to its retrospective nature. First, the two techniques were performed by two individual surgeons, leading to a potential selection bias. Second, considering this small population and insufficient follow-up time, we were unable to conclude the advantage of the novel technique in terms of the recurrent-free survival. Further prospective study with a larger population and long-term follow-up is warranted.

Conclusions

We report a novel procedure of en bloc resection of non-muscle-invasive bladder tumors with conventional monopolar resection setting. Compared to conventional TURBT, this technique is safe and effective with the added merits of obtaining better quality tumor specimens which may allow for accurate histopathological diagnosis and staging.

Abbreviations

C-TURBT: 

Conventional transurethral resection of bladder tumor

EAU: 

European Association of Urology

ERBT: 

En bloc resection of bladder tumor

ESRBT: 

Endoscopic snare resection technique

NMIBC: 

Non-muscle-invasive bladder cancer

RERBT: 

Retrograde en bloc resection of bladder tumor

TURBT: 

Transurethral resection of bladder tumor

WHO: 

World Health Organization

Declarations

Acknowledgements

We thank Prof. Long-Cheng Li for critical reading and editing of our manuscript.

Funding

None.

Availability of data and materials

All the data of the case report are included in this manuscript.

Authors’ contributions

K-YZ handled project development, performed RERBT, participated in data collection, and undertook the manuscript writing. J-CX handled project development. WL performed TURBT and participated in data collection. ZW and BC participated in data collection. D-YB handled the pathological analysis. All authors read and approved the final manuscript.

Ethics approval and consent to participate

This study was approved by the Ethics Committee of Xiamen University Affiliated First Hospital.

Consent for publication

All patients enrolled in the study signed the consent for publication.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Urology, Xiamen University Affiliated First Hospital
(2)
Department of Pathology, Xiamen University Affiliated First Hospital

References

  1. Rl S, Kd M, Aa J, Aa J. Cancer statistics. CA Cancer J Clin. 2015;65(1):5–29.View ArticleGoogle Scholar
  2. Xishuang S, Deyong Y, Xiangyu C, et al. Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer. J Endourol. 2010;24(1):69–73. doi:10.1089/end.2009.0171 .View ArticlePubMedGoogle Scholar
  3. Sureka SK, Agarwal V, Agnihotri S, et al. Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression?: A prospective study. Indian J Urol. 2014;30(2):144–9. doi:10.4103/0970-1591.126887 .View ArticlePubMedPubMed CentralGoogle Scholar
  4. Babjuk M, Burger M, Zigeuner R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013;64(4):639–53. doi:10.1016/j.eururo.2013.06.003 .View ArticlePubMedGoogle Scholar
  5. Gontero P, Sylvester R, Pisano F, et al. Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guerin: results of a retrospective multicenter study of 2451 patients. Eur Urol. 2015;67(1):74–82. doi:10.1016/j.eururo.2014.06.040 .View ArticlePubMedGoogle Scholar
  6. Herr HW, Donat SM. Quality control in transurethral resection of bladder tumours. BJU Int. 2008;102(9 Pt B):1242–6. doi:10.1111/j.1464-410X.2008.07966.x.View ArticlePubMedGoogle Scholar
  7. Ornstein DK. Pathology and genetics: tumours of the urinary system and male genital organs. J Urol. 2004;172(6, Part 1):2511. doi:10.1097/01.ju.0000145260.89322.2d .View ArticleGoogle Scholar
  8. de Nunzio C, Franco G, Cindolo L, et al. Transuretral resection of the bladder (TURB): analysis of complications using a modified Clavien system in an Italian real life cohort. Eur J Surg Oncol. 2014;40(1):90–5. doi:10.1016/j.ejso.2013.11.003 .View ArticlePubMedGoogle Scholar
  9. Maurice MJ, Vricella GJ, MacLennan G, et al. Endoscopic snare resection of bladder tumors: evaluation of an alternative technique for bladder tumor resection*. J Endourol. 2012;26(6):614–7. doi:10.1089/end.2011.0587 .View ArticlePubMedGoogle Scholar
  10. Bach T, Muschter R, Herrmann TR, et al. Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: Summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future pers. BJU Int. 2015;115(1):14–23. doi:10.1111/bju.12664 .View ArticlePubMedGoogle Scholar
  11. Kramer MW, Rassweiler JJ, Klein J, et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol. 2015;33(12):1937–43. doi:10.1007/s00345-015-1568-6 .View ArticlePubMedGoogle Scholar
  12. Ukai R, Kawashita E, Ikeda H. A new technique for transurethral resection of superficial bladder tumor in 1 piece. J Urol. 2000;163(3):878–9.View ArticlePubMedGoogle Scholar
  13. Hurle R, Lazzeri M, Colombo P, et al. “En bloc” resection of nonmuscle invasive bladder cancer: a prospective single-center study. Urology. 2016;90:126–30. doi:10.1016/j.urology.2016.01.004 .View ArticlePubMedGoogle Scholar
  14. Oh KJ, Choi Y-D, Chung HS, et al. A novel transurethral resection technique for superficial flat bladder tumor: grasp and bite technique. Korean J Urol. 2015;56(3):227–32. doi:10.4111/kju.2015.56.3.227 .View ArticlePubMedPubMed CentralGoogle Scholar
  15. Zhong C, Guo S, Tang Y, et al. Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience. World J Urol. 2010;28(2):157–61. doi:10.1007/s00345-010-0532-8 .View ArticlePubMedGoogle Scholar
  16. Nagele U, Kugler M, Nicklas A, et al. Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resection. World J Urol. 2011;29(4):423–7. doi:10.1007/s00345-011-0653-8 .View ArticlePubMedGoogle Scholar
  17. Fritsche H-M, Otto W, Eder F, et al. Water-jet-aided transurethral dissection of urothelial carcinoma: a prospective clinical study. J Endourol. 2011;25(10):1599–603. doi:10.1089/end.2011.0042 .View ArticlePubMedGoogle Scholar
  18. Thomas K, O’Brien T. Improving transurethral resection of bladder tumour: the gold standard for diagnosis and treatment of bladder tumours. Eur Urol Suppl. 2008;7(7):524–8. doi:10.1016/j.eursup.2008.04.003 .View ArticleGoogle Scholar
  19. Kramer MW, Wolters M, Herrmann TR (2016) En bloc resection of bladder tumors: ready for prime time? European urology. doi: 10.1016/j.eururo.2016.01.004 Google Scholar
  20. Migliari R, Buffardi A, Ghabin H. Thulium laser endoscopic en bloc enucleation of nonmuscle-invasive bladder cancer. J Endourol. 2015;29(11):1258–62. doi:10.1089/end.2015.0336 .View ArticlePubMedGoogle Scholar
  21. Weizer AZ, Wasco MJ, Wang R, et al. Multiple adverse histological features increase the odds of under staging T1 bladder cancer. J Urol. 2009;182(1):59–65. doi:10.1016/j.juro.2009.02.116 . discussion 65.View ArticlePubMedGoogle Scholar
  22. Coblentz TR, Mills SE, Theodorescu D. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma. Cancer. 2001;91(7):1284–90. doi:10.1002/1097-0142(20010401)91:7<1284:AID-CNCR1130>3.0.CO;2-E .View ArticlePubMedGoogle Scholar
  23. BRAUERS A, BUETTNER R, Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol. 2001;165(3):808–10. doi:10.1016/S0022-5347(05)66532-9 .View ArticlePubMedGoogle Scholar
  24. Muto G, Collura D, Giacobbe A, et al. Thulium: yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages. Urology. 2014;83(4):851–5. doi:10.1016/j.urology.2013.12.022 .View ArticlePubMedGoogle Scholar
  25. Xu Y, Guan W, Chen W, et al. Comparing the treatment outcomes of potassium-titanyl-phosphate laser vaporization and transurethral electroresection for primary nonmuscle-invasive bladder cancer: a prospective, randomized study. Lasers Surg Med. 2015;47(4):306–11. doi:10.1002/lsm.22342 .View ArticlePubMedGoogle Scholar
  26. Naselli A, Introini C, Germinale F, et al. En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm. BJU Int. 2012;109(6):960–3. doi:10.1111/j.1464-410X.2012.10982.x .View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement